Fund shareholders of Vertex Pharmaceuticals Inc
ISIN US92532F1003 · United States · LEI 54930015RAQRRZ5ZGJ91
- Fund shareholders
- 1,205
- Of which ETFs
- 310 895 other funds
- Value held
- 56.9B $ 143.7M € · 5.3B SEK
1,205 funds hold this company. This table lists the 1,185 that declare it in a regulatory filing. The other 20 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| ProShares UltraPro S&P500 ProShares Trust | 11,798 | 5.9M $ | 0.13 % | as of Feb 28, 2026 ↗ |
| World Selection Index Fund Northern Funds | 11,736 | 5.2M $ | 0.27 % | as of Mar 31, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 11,723 | 5.2M $ | 0.10 % | as of Mar 31, 2026 ↗ |
| Victory Pioneer Balanced Fund Victory Portfolios IV | 11,700 | 5M $ | 1.07 % | as of Apr 30, 2026 ↗ |
| Nationwide Large Cap Equity Portfolio Nationwide Mutual Funds | 11,680 | 5M $ | 0.26 % | as of Apr 30, 2026 ↗ |
| VOYA U.S. STOCK INDEX PORTFOLIO Voya Investors Trust | 11,644 | 5.2M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 11,581 | 5.8M $ | 6.27 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 11,542 | 5.2M $ | 0.09 % | as of Mar 31, 2026 ↗ |
| Federated Hermes MDT All Cap Core Fund Federated Hermes MDT Series | 11,489 | 4.9M $ | 0.14 % | as of Apr 30, 2026 ↗ |
| Optimum Large Cap Growth Fund Optimum Fund Trust | 11,455 | 5.1M $ | 0.30 % | as of Mar 31, 2026 ↗ |
| LVIP Loomis Sayles Global Growth Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 11,449 | 5.1M $ | 2.24 % | as of Mar 31, 2026 ↗ |
| ULTRANASDAQ-100 PROFUND ProFunds | 11,449 | 4.9M $ | 0.37 % | as of Apr 30, 2026 ↗ |
| Nomura VIP Core Equity Series Ivy Variable Insurance Portfolios | 11,408 | 5.1M $ | 0.79 % | as of Mar 31, 2026 ↗ |
| U.S. Socially Responsible Fund VALIC Co I | 11,366 | 5.6M $ | 1.20 % | as of Feb 28, 2026 ↗ |
| American Funds Global Balanced Fund AMERICAN FUNDS INSURANCE SERIES | 11,248 | 5M $ | 1.13 % | as of Mar 31, 2026 ↗ |
| Invesco S&P 500 Revenue ETF Invesco Exchange-Traded Fund Trust II | 11,178 | 5.6M $ | 0.07 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 500 Fossil Fuel Reserves Free ETF SPDR SERIES TRUST | 10,978 | 4.9M $ | 0.21 % | as of Mar 31, 2026 ↗ |
| AZL S&P 500 Index Fund Allianz Variable Insurance Products Trust | 10,972 | 4.9M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| BNY Mellon S&P 500 Index Fund BNY MELLON INDEX FUNDS, INC. | 10,967 | 4.7M $ | 0.17 % | as of Apr 30, 2026 ↗ |
| iShares Dow Jones U.S. ETF iShares Trust | 10,944 | 4.7M $ | 0.16 % | as of Apr 30, 2026 ↗ |
| AQR Long-Short Equity Fund AQR Funds | 10,684 | 4.8M $ | 0.06 % | as of Mar 31, 2026 ↗ |
| THRIVENT MODERATE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 10,638 | 4.8M $ | 0.06 % | as of Mar 31, 2026 ↗ |
| JPMorgan U.S. GARP Equity Fund JPMorgan Trust I | 10,619 | 4.7M $ | 0.26 % | as of Mar 31, 2026 ↗ |
| Columbia Variable Portfolio - Large Cap Index Fund Columbia Funds Variable Series Trust II | 10,519 | 4.7M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| LargeCap S&P 500 Index Account Principal Variable Contract Funds, Inc | 10,501 | 4.7M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| Franklin Systematic Style Premia ETF Franklin Templeton ETF Trust | 10,459 | 4.7M $ | 0.68 % | as of Mar 31, 2026 ↗ |
| THRIVENT MODERATELY AGGRESSIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 10,457 | 4.7M $ | 0.06 % | as of Mar 31, 2026 ↗ |
| NASDAQ-100(R) 2x Strategy Fund Rydex Dynamic Funds | 10,452 | 4.7M $ | 0.42 % | as of Mar 31, 2026 ↗ |
| Aristotle Core Equity Fund Aristotle Fund Series Trust | 10,347 | 4.6M $ | 0.89 % | as of Mar 31, 2026 ↗ |
| iShares Russell Top 200 ETF iShares Trust | 10,305 | 4.6M $ | 0.24 % | as of Mar 31, 2026 ↗ |
| Virtus KAR Health Sciences Fund Virtus Investment Trust | 10,236 | 4.6M $ | 5.09 % | as of Mar 31, 2026 ↗ |
| ATM Large Cap Managed Volatility Portfolio EQ Advisors Trust | 10,227 | 4.6M $ | 0.18 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 9,910 | 4.2M $ | 0.27 % | as of Apr 30, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 9,860 | 4.2M $ | 0.81 % | as of Apr 30, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 9,802 | 4.9M $ | 0.00 % | as of Feb 28, 2026 ↗ |
| NVIT BNY Mellon Dynamic U.S. Core Fund Nationwide Variable Insurance Trust | 9,783 | 4.4M $ | 0.19 % | as of Mar 31, 2026 ↗ |
| Skandia USA Skandia Fonder AB | 9,716 | 41.3M SEK | 0.91 % | as of Mar 31, 2026 ↗ |
| VANGUARD BAILLIE GIFFORD GLOBAL POSITIVE IMPACT STOCK FUND VANGUARD VALLEY FORGE FUNDS | 9,709 | 4.3M $ | 1.73 % | as of Mar 31, 2026 ↗ |
| THRIVENT LARGE CAP INDEX PORTFOLIO Thrivent Series Fund, Inc. | 9,615 | 4.3M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| Transamerica Janus Balanced VP TRANSAMERICA SERIES TRUST | 9,579 | 4.3M $ | 0.56 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Tax-Efficient Equity Fund T. ROWE PRICE TAX-EFFICIENT FUNDS, INC. | 9,399 | 4.7M $ | 0.34 % | as of Feb 28, 2026 ↗ |
| AST Large-Cap Equity Portfolio Advanced Series Trust | 9,382 | 4.2M $ | 0.24 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Research Portfolio JANUS ASPEN SERIES | 9,297 | 4.2M $ | 0.62 % | as of Mar 31, 2026 ↗ |
| Victory Growth & Income Fund Victory Portfolios III | 9,264 | 4M $ | 0.18 % | as of Apr 30, 2026 ↗ |
| Monthly Rebalance NASDAQ-100 2x Strategy Fund Rydex Series Funds | 9,234 | 4.1M $ | 0.50 % | as of Mar 31, 2026 ↗ |
| PD Large-Cap Growth Index Portfolio PACIFIC SELECT FUND | 9,183 | 4.1M $ | 0.39 % | as of Mar 31, 2026 ↗ |
| CVT Nasdaq-100 Index Portfolio Calvert Variable Trust, Inc. | 9,172 | 4.1M $ | 0.62 % | as of Mar 31, 2026 ↗ |
| MM S&P 500 Index Fund MASSMUTUAL SELECT FUNDS | 9,159 | 4.1M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| Tax-Aware Overlay A Portfolio BERNSTEIN SANFORD C FUND INC | 9,106 | 4.1M $ | 0.52 % | as of Mar 31, 2026 ↗ |
| Aptus Collared Investment Opportunity ETF ETF Series Solutions | 9,103 | 3.9M $ | 0.17 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Global Research Portfolio JANUS ASPEN SERIES | 9,046 | 4M $ | 0.42 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 8,804 | 3.9M $ | 2.47 % | as of Mar 31, 2026 ↗ |
| EQ/ClearBridge Select Equity Managed Volatility Portfolio EQ Advisors Trust | 8,798 | 3.9M $ | 0.67 % | as of Mar 31, 2026 ↗ |
| Invesco MSCI North America Climate ETF Invesco Exchange-Traded Fund Trust II | 8,726 | 4.3M $ | 0.35 % | as of Feb 28, 2026 ↗ |
| Pro-Blend Extended Term Series Manning & Napier Fund, Inc. | 8,718 | 3.7M $ | 0.96 % | as of Apr 30, 2026 ↗ |
| Large Capital Growth Fund VALIC Co I | 8,701 | 4.3M $ | 0.55 % | as of Feb 28, 2026 ↗ |
| THRIVENT HEALTHCARE PORTFOLIO Thrivent Series Fund, Inc. | 8,669 | 3.9M $ | 1.74 % | as of Mar 31, 2026 ↗ |
| Harbor Long-Term Growers ETF Harbor ETF Trust | 8,643 | 3.7M $ | 0.34 % | as of Apr 30, 2026 ↗ |
| Venerable World Equity Fund Venerable Variable Insurance Trust | 8,628 | 3.9M $ | 0.37 % | as of Mar 31, 2026 ↗ |
| Domini Impact Equity Fund Domini Investment Trust | 8,603 | 3.7M $ | 0.31 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs MarketBeta U.S. 1000 Equity ETF Goldman Sachs ETF Trust II | 8,589 | 4.3M $ | 0.20 % | as of Feb 28, 2026 ↗ |
| iShares ESG MSCI USA Leaders ETF iShares Trust | 8,535 | 4.2M $ | 0.41 % | as of Feb 28, 2026 ↗ |
| Leuthold Core Investment Fund Managed Portfolio Series | 8,471 | 3.8M $ | 0.71 % | as of Mar 31, 2026 ↗ |
| AMF Balansfond AMF Fonder AB | 8,432 | 35.9M SEK | 0.14 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Growth ETF iShares Trust | 8,317 | 3.6M $ | 0.12 % | as of Apr 30, 2026 ↗ |
| NYLI S&P 500 Index Fund NEW YORK LIFE INVESTMENTS FUNDS TRUST | 8,268 | 3.5M $ | 0.17 % | as of Apr 30, 2026 ↗ |
| JNL/BlackRock Global Allocation Fund JNL Series Trust | 8,253 | 3.7M $ | 0.15 % | as of Mar 31, 2026 ↗ |
| Deutsche DWS Equity 500 Index Portfolio DEUTSCHE DWS EQUITY 500 INDEX PORTFOLIO | 8,182 | 3.7M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| SA JPMorgan Large Cap Core Portfolio SUNAMERICA SERIES TRUST | 8,137 | 3.5M $ | 0.66 % | as of Apr 30, 2026 ↗ |
| Swedbank Humanfond Swedbank Robur Fonder AB | 8,078 | 34.4M SEK | 1.24 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Variable Insurance Trust U.S. Equity Insights Fund Goldman Sachs Variable Insurance Trust | 8,053 | 3.6M $ | 1.05 % | as of Mar 31, 2026 ↗ |
| Simplify Health Care ETF Simplify Exchange Traded Funds | 8,020 | 3.6M $ | 1.53 % | as of Mar 31, 2026 ↗ |
| AST Balanced Asset Allocation Portfolio Advanced Series Trust | 8,007 | 3.6M $ | 0.02 % | as of Mar 31, 2026 ↗ |
| VALUE LINE CAPITAL APPRECIATION FUND INC VALUE LINE CAPITAL APPRECIATION FUND INC | 8,000 | 3.6M $ | 0.77 % | as of Mar 31, 2026 ↗ |
| First Trust Health Care AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 7,945 | 3.4M $ | 0.39 % | as of Apr 30, 2026 ↗ |
| Dimensional US Sustainability Core 1 ETF Dimensional ETF Trust | 7,905 | 3.4M $ | 0.16 % | as of Apr 30, 2026 ↗ |
| Guardian Large Cap Disciplined Growth VIP Fund Guardian Variable Products Trust | 7,890 | 3.5M $ | 1.17 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Blend Fund Prudential Jennison Blend Fund, Inc. | 7,843 | 3.9M $ | 0.36 % | as of Feb 27, 2026 ↗ |
| PGIM Jennison Diversified Growth Fund Prudential Investment Portfolios 5 | 7,804 | 3.3M $ | 0.76 % | as of Apr 30, 2026 ↗ |
| Nationwide S&P 500 Index Fund Nationwide Mutual Funds | 7,619 | 3.3M $ | 0.17 % | as of Apr 30, 2026 ↗ |
| SIIT LARGE CAP INDEX FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 7,610 | 3.8M $ | 0.19 % | as of Feb 28, 2026 ↗ |
| Growth Equity Index Fund GuideStone Funds | 7,546 | 3.4M $ | 0.49 % | as of Mar 31, 2026 ↗ |
| Baron Health Care Fund BARON SELECT FUNDS | 7,500 | 3.3M $ | 2.79 % | as of Mar 31, 2026 ↗ |
| TAX MANAGED MULTI CAP GROWTH PORTFOLIO Tax-Managed Multi-Cap Growth Portfolio | 7,471 | 3.2M $ | 1.06 % | as of Apr 30, 2026 ↗ |
| JNL/AQR Large Cap Defensive Style Fund JNL Series Trust | 7,469 | 3.3M $ | 0.82 % | as of Mar 31, 2026 ↗ |
| Destinations Large Cap Equity Fund Brinker Capital Destinations Trust | 7,464 | 3.7M $ | 0.11 % | as of Feb 28, 2026 ↗ |
| The Institutional U.S. Equity Portfolio HC Capital Trust | 7,450 | 3.3M $ | 0.12 % | as of Mar 31, 2026 ↗ |
| Victory Pioneer Disciplined Value Fund Victory Portfolios IV | 7,324 | 3.6M $ | 0.86 % | as of Feb 28, 2026 ↗ |
| Schwab Large-Cap Growth Fund SCHWAB CAPITAL TRUST | 7,301 | 3.1M $ | 0.53 % | as of Apr 30, 2026 ↗ |
| iShares MSCI Global Sustainable Development Goals ETF iShares Trust | 7,182 | 3.6M $ | 2.10 % | as of Feb 28, 2026 ↗ |
| Lysa Global Equity Broad Lysa Fonder AB | 7,101 | 30.2M SEK | 0.15 % | as of Mar 31, 2026 ↗ |
| Allspring Special Large Value ETF ALLSPRING EXCHANGE-TRADED FUNDS TRUST | 7,081 | 3M $ | 1.36 % | as of Apr 30, 2026 ↗ |
| Putnam VT Global Health Care Fund Putnam Variable Trust | 7,080 | 3.2M $ | 2.24 % | as of Mar 31, 2026 ↗ |
| State Street S&P 500 Index Fund SSGA FUNDS | 7,062 | 3.5M $ | 0.22 % | as of Feb 28, 2026 ↗ |
| Wahed FTSE USA Shariah ETF Listed Funds Trust | 7,051 | 3.5M $ | 0.46 % | as of Feb 28, 2026 ↗ |
| First Trust NASDAQ-100 Ex-Technology Sector Index Fund First Trust Exchange-Traded Fund | 7,015 | 3.1M $ | 1.73 % | as of Mar 31, 2026 ↗ |
| Franklin U.S. Equity Index ETF Franklin Templeton ETF Trust | 7,007 | 3.1M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| SFT Index 500 Fund Securian Funds Trust | 6,899 | 3.1M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| George Putnam Balanced Fund George Putnam Balanced Fund | 6,874 | 2.9M $ | 0.13 % | as of Apr 30, 2026 ↗ |
| LVIP BlackRock Global Allocation Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 6,804 | 3M $ | 0.15 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 9.30 % | as of Feb 28, 2026 ↗ |
| Direxion Daily Biotech Top 5 Bull 2X ETF Direxion Shares ETF Trust | 8.22 % | as of Apr 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 8.06 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 7.44 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 6.27 % | as of Feb 28, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 5.60 % | as of Mar 31, 2026 ↗ |
| ClearBridge Growth Fund Legg Mason Partners Investment Trust | 5.44 % | as of Feb 27, 2026 ↗ |
| ClearBridge Variable Growth Portfolio Legg Mason Partners Variable Equity Trust | 5.33 % | as of Mar 31, 2026 ↗ |
| Virtus KAR Health Sciences Fund Virtus Investment Trust | 5.09 % | as of Mar 31, 2026 ↗ |
| BNP Paribas Funds Health Care Innovators BNP Paribas Asset Management Luxembourg | 4.90 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1,048 | +76 | 123,815,099 | +2.9 % |
| 2026Q1 | 972 | -29 | 120,276,157 | +1.8 % |
| 2025Q4 | 1,001 | -22 | 118,183,576 | -3.6 % |
| 2025Q3 | 1,023 | -31 | 122,642,833 | +1.6 % |
| 2025Q2 | 1,054 | +33 | 120,769,763 | +3.2 % |
| 2025Q1 | 1,021 | -78 | 117,052,590 | +2.0 % |
| 2024Q4 | 1,099 | -59 | 114,791,743 | +0.8 % |
| 2024Q3 | 1,158 | -31 | 113,844,744 | +1.6 % |
| 2024Q2 | 1,189 | -2 | 112,003,751 | +5.6 % |
| 2024Q1 | 1,191 | -6 | 106,033,489 | -4.0 % |
| 2023Q4 | 1,197 | 110,442,131 |
Institutional managers
1,670 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Capital World Investors | 25,368,124 | 11.3B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 23,969,517 | 10.7B $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 21,125,964 | 9.4B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 11,730,139 | 5.2B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 7,033,156 | 3.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 6,139,621 | 2.7B $ | as of Mar 31, 2026 |
| Capital International Investors | 5,126,077 | 2.3B $ | as of Mar 31, 2026 |
| LOOMIS SAYLES & CO L P | 4,003,821 | 1.8B $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 3,910,786 | 1.8B $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 3,212,589 | 1.4B $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 3,188,881 | 1.4B $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3,057,396 | 1.4B $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 2,878,183 | 1.3B $ | as of Mar 31, 2026 |
| JENNISON ASSOCIATES LLC | 2,740,059 | 1.2B $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 2,700,975 | 1.2B $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 2,633,481 | 1.2B $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 2,564,264 | 1.1B $ | as of Mar 31, 2026 |
| Invesco Ltd. | 2,561,057 | 1.1B $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,417,875 | 1.1B $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 2,131,527 | 951.8M $ | as of Mar 31, 2026 |
| FMR LLC | 2,020,265 | 902.1M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 1,955,764 | 873.3M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,920,871 | 857.7M $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 1,888,521 | 843.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,760,122 | 786K $ | as of Mar 31, 2026 |
Declared shareholders of Vertex Pharmaceuticals Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Capital World Investors | 10.10 % | 25,695,015 | as of Mar 31, 2026 · SCHEDULE 13G |
| Capital Research Global Investors | 8.30 % | 21,139,169 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 7.49 % | 19,036,076 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Vertex Pharmaceuticals Inc". https://titelia.com/en/stocks/vertex-pharmaceuticals-inc-US92532F1003